The European Network for Light Ion Hadron Therapy (ENLIGHT) was established in 2002 following various European particle therapy network initiatives during the 1980s and 1990s (e.g. EORTC task group, EULIMA/PIMMS accelerator design). ENLIGHT started its work on major topics related to hadron therapy (HT), such as patient selection, clinical trials, technology, radiobiology, imaging and health economics. It was initiated through CERN and ESTRO and dealt with various disciplines such as (medical) physics and engineering, radiation biology and radiation oncology.
from Imaging via alkiviadis.1961 on Inoreader https://ift.tt/2Iqa14a
Τρίτη 3 Απριλίου 2018
ENLIGHT: European network for Light ion hadron therapy
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: January 2017 Source: International Journal of Biological Macromolecules, Volume 94, Part A Author(s): Vinicius Jose Silv...
-
Background Moyamoya angiopathy (MMA) is characterised by a progressive stenosis of the terminal part of the internal carotid arteries and th...
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Shehwaz Anwar, Hina Youn...
-
Communicating with patients at the end of life is regarded as a difficult task, and speaking openly about death is often avoided.1,2 Around ...
-
Pyrexia is a physiological response through which the immune system responds to infectious processes. Hyperpyrexia is known to be neurodegen...
-
A. M. Y. Yong, SS Yang, KB Tan, SA Ho Indian Dermatology Online Journal 2017 8(3):192-194 The Trichosporon species are yeast-like opport...
-
Mucoepidermoid carcinoma is the most common malignant, locally invasive tumour of the salivary glands and accounts for approximately 35% of ...
-
Abstract The core mission of the Early Stage Professionals in Molecular Imaging Sciences (ESPMIS) Interest Group is to help young scientist...
-
BACKGROUND AND PURPOSE: Treatment with bevacizumab is standard of care for recurrent high-grade gliomas; however, monitoring response to ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου